Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Forbion Growth Opportunities Fund I Cooperatief U.A.
10% owner at enGene Therapeutics. Filing since 27 Dec 2023.
CIK 0001911047
Company
Date
Role
Action
Shares
Amount
Of holding
ENGN
enGene Therapeutics Inc.
30 Oct 2024
10% owner
Bought
561,797
$5.00M
22.7%
ENGN
enGene Therapeutics Inc.
8 Oct 2024
10% owner
Bought
800
$5.28K
0.0%
ENGN
enGene Therapeutics Inc.
7 Oct 2024
10% owner
Bought
11,844
$77.53K
0.5%
ENGN
enGene Therapeutics Inc.
4 Oct 2024
10% owner
Bought
5,997
$39.24K
0.2%
ENGN
enGene Therapeutics Inc.
3 Oct 2024
10% owner
Bought
5,769
$37.40K
0.2%
ENGN
enGene Therapeutics Inc.
2 Oct 2024
10% owner
Bought
10,153
$64.70K
0.4%
ENGN
enGene Therapeutics Inc.
1 Oct 2024
10% owner
Bought
35,279
$227.16K
1.5%
ENGN
enGene Therapeutics Inc.
30 Sep 2024
10% owner
Bought
341,332
$2.16M
16.6%
ENGN
enGene Therapeutics Inc.
27 Sep 2024
10% owner
Bought
41,639
$248.70K
2.1%
ENGN
enGene Therapeutics Inc.
29 Dec 2023
10% owner
Bought
10,020
$90.77K
0.5%
ENGN
enGene Therapeutics Inc.
28 Dec 2023
10% owner
Bought
5,050
$38.83K
0.3%
ENGN
enGene Therapeutics Inc.
27 Dec 2023
10% owner
Bought
2,750
$19.71K
0.1%
12 decisions on file.
